Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over
No. | 薬物名(臨床試験情報から抽出) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY On map, Yellow: Drug target genes |
指定難病告示番号 |
1 | Bmn 110 | - | - | - | - | 019 1件: 19 💬 |
2 | Bmn 110 - every other week | - | - | - | - | 019 1件: 19 💬 |
3 | Bmn 110 - weekly | - | - | - | - | 019 1件: 19 💬 |
4 | Bmn 110 every other week | - | - | - | - | 019 1件: 19 💬 |
5 | Bmn 110 weekly | - | - | - | - | 019 1件: 19 💬 |
6 | Recombinant human n-acetylgalactosamine 6-sulfatase, bmn 110 | - | - | - | - | 019 1件: 19 💬 |
7 | Recombinant human n-acetylgalactosamine 6-sulfatase, bmn 110 drug substance | - | - | - | - | 019 1件: 19 💬 |
8 | Recombinant human n-acetylgalactosamine-6-sulfatase, bmn 110 | Elosulfase alfa | 1件: D10333 D10333 💬 |
GALNS 1件: GALNS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |
9 | Recombinant human n-acetylgalactosamine-6-sulfatase, bmn 110 drug substance | Elosulfase alfa | 1件: D10333 D10333 💬 |
GALNS 1件: GALNS 💬 |
Glycosaminoglycan degradation 3件: Glycosaminoglycan degradation, Lysosome, Metabolic pathways |
019 1件: 19 💬 |